<p>2025 年 11 月 14 日- 下午 02:49</p>
<p>德克萨斯州小橡树——（商业资讯）——Retractable Technologies, Inc.（纽约证券交易所代码：RVP）宣布其 EasyPoint®血液采集管支架及针头获得了 Vizient®的创新技术认证，这是美国最大的医疗保健绩效改善公司。</p>
<p>每年，服务于 Vizient 客户主导委员会的医疗保健专家会审查特定产品和技术，以评估其在提升临床护理、患者安全、医疗工作者安全或改善医疗组织业务运营方面的潜力。创新技术认证授予之前已签约的产品，以向医疗服务提供者传达这些创新对患者护理和医疗组织商业模式的影响。</p>
<p>RTI 的创新 EasyPoint 血液采集管支架（BCTH）及针头采用自动回缩技术，提供即时安全，允许在静脉内激活，已证明能有效减少接触被污染针头的风险，并降低针刺伤害的风险。EasyPoint BCTH 及针头安全且易于使用，开箱即用。预装针头消除了使用前组装的需要，提高了准备时间和工作流程的效率，同时简化了库存管理。集成的低调安全机制提供了最佳的静脉穿刺视野，促进首次尝试的成功。附带的薄壁针头经过三重斜面处理并润滑，以提高患者舒适度。独特的离线回缩可单手操作，无需显著改变技术或握持方式，也不需要向下运动，从而降低患者不适的风险。回缩后，整个针头（前端和后端）完全被覆盖且无法接触，相比之下，许多其他管支架的后端针头仍然暴露且可接触。一旦激活，该产品将被视为不可重复使用，并防止针头移除，以符合安全规定。</p>
<p>“我们深感荣幸，EasyPoint 血液采集管支架及针头获得了 Vizient 的创新技术认证，” Retractable Technologies, Inc.首席执行官 Thomas Shaw 表示。“这一认可确认了我们在医疗环境中开发提供安全、高效和可靠解决方案的持续承诺。从一开始，我们的使命就是通过工程卓越和创新来保护患者和临床医生，而 EasyPoint 设备正是这一使命的体现。我们为团队的奉献精神得到行业内最受尊敬的组织之一的认可而感到自豪。”</p>
<p>“祝贺 Retractable Technologies, Inc.获得这一同行认证的地位，” Vizient 合同运营副总裁 Kelly Flaharty 表示。“我们的客户委员会认为 EasyPoint 血液采集管支架及针头值得获得这一认证，因为它在医疗行业中具有真正的影响潜力。”</p>
<p><strong>可回缩</strong></p>
<p>Retractable 生产和销售 VanishPoint®、EasyPoint®和 Patient Safe®安全医疗产品。VanishPoint®注射器、血液采集和静脉导管产品旨在通过直接从患者体内回缩针头来防止针刺伤害和产品重复使用，有效减少接触被污染针头的风险。Patient Safe®注射器独特设计旨在降低因导管接头污染而导致的血流感染风险。EasyPoint®可回缩针头可与 luer 锁注射器、luer 滑动注射器和预填充注射器一起使用进行注射。EasyPoint®针头还可用于抽取液体和血液采集。Retractable 的产品通过各种专业和一般分销商进行分销。</p>
<p>有关 Retractable 的更多信息，请访问其网站 www.retractable.com。</p>
<p>本新闻稿中的前瞻性声明是根据 1995 年《私人证券诉讼改革法》的安全港条款作出的，反映了 Retractable 对未来事件的当前看法。Retractable 相信这些前瞻性声明所反映的期望是准确的。然而，Retractable 无法保证这些期望会实现。实际未来表现可能与这些声明存在重大差异。</p>
<p>可能导致或促成这些差异的因素包括但不限于：需求的重大变化；关税；Retractable 维持流动性的能力；Retractable 维持专利保护的能力；Retractable 维持有利的第三方制造和供应商安排及关系的能力；外贸风险；Retractable 进入市场的能力；生产成本；大型市场参与者在安全市场提供设备的影响；以及其他不时在 Retractable 定期报告中详细说明的风险和不确定性，这些报告已提交给美国证券交易委员会。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTExMTQ2NDE4NzNyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTExMTQ2NDE4NzNyMQ"/></p>
<p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251114641873/en/</p>
<p>Retractable Technologies, Inc.</p>
<p>John W. Fort III, 888-806-2626 或 972-294-1010</p>
<p>副总裁、首席财务官和首席会计官</p>
<p>来源：Retractable Technologies, Inc.</p>

Retractable技术

<p>可伸缩技术公司（Retractable Technologies, Inc.）宣布，其 EasyPoint 血液采集管夹具及针头获得了领先的医疗保健绩效改善公司 Vizient 的创新技术认证。这一认可突显了该产品在提升临床护理和安全性方面的潜力。EasyPoint 设备具有自动回缩功能，确保安全、高效和可靠，减少针刺伤害并改善工作流程。首席执行官托马斯·肖（Thomas Shaw）对这一认可表示自豪，重申了公司在医疗保健领域对安全和创新的承诺</p>

<p>11/14/2025 - 02:49 PM</p>
<div class="lb-trans"><p>2025 年 11 月 14 日- 下午 02:49</p>
</div><p>LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announces its EasyPoint® Blood Collection Tube Holder with Needle has received an Innovative Technology designation from Vizient®, the largest healthcare performance improvement company in the country.</p>
<div class="lb-trans"><p>德克萨斯州小橡树——（商业资讯）——Retractable Technologies, Inc.（纽约证券交易所代码：RVP）宣布其 EasyPoint®血液采集管支架及针头获得了 Vizient®的创新技术认证，这是美国最大的医疗保健绩效改善公司。</p>
</div><p>Each year, healthcare experts serving on one of Vizient’s client-led councils review select products and technologies for their potential to enhance clinical care, patient safety, healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers the impact of these innovations on patient care and business models of healthcare organizations.</p>
<div class="lb-trans"><p>每年，服务于 Vizient 客户主导委员会的医疗保健专家会审查特定产品和技术，以评估其在提升临床护理、患者安全、医疗工作者安全或改善医疗组织业务运营方面的潜力。创新技术认证授予之前已签约的产品，以向医疗服务提供者传达这些创新对患者护理和医疗组织商业模式的影响。</p>
</div><p>RTI’s innovative EasyPoint Blood Collection Tube Holder (BCTH) with Needle uses automated retraction to provide instant safety by allowing for in-vein activation, proven to effectively reduce exposure to the contaminated needle and reduce the risk of needlestick injuries. The EasyPoint BCTH with Needle is safe and easy to use right out of the package. The pre-attached needle eliminates the need for assembly prior to use, improving efficiency in preparation time and workflow, as well as streamlining inventory. The integrated, low-profile safety mechanism provides an optimal view of the venipuncture site, promoting first-attempt success. The attached thin-wall needle is triple-beveled and lubricated for patient comfort. The unique, off-line retraction is achieved using one hand without significant change in technique or grip, and does not require any downward motion, reducing the risk of patient discomfort. Upon retraction, the entire needle (front and back end) is completely covered and inaccessible, compared to back-end needles that remain exposed and accessible via the open end of many other tube holders. Once activated, the product is rendered non-reusable and prevents needle removal, in compliance with safety regulations.</p>
<div class="lb-trans"><p>RTI 的创新 EasyPoint 血液采集管支架（BCTH）及针头采用自动回缩技术，提供即时安全，允许在静脉内激活，已证明能有效减少接触被污染针头的风险，并降低针刺伤害的风险。EasyPoint BCTH 及针头安全且易于使用，开箱即用。预装针头消除了使用前组装的需要，提高了准备时间和工作流程的效率，同时简化了库存管理。集成的低调安全机制提供了最佳的静脉穿刺视野，促进首次尝试的成功。附带的薄壁针头经过三重斜面处理并润滑，以提高患者舒适度。独特的离线回缩可单手操作，无需显著改变技术或握持方式，也不需要向下运动，从而降低患者不适的风险。回缩后，整个针头（前端和后端）完全被覆盖且无法接触，相比之下，许多其他管支架的后端针头仍然暴露且可接触。一旦激活，该产品将被视为不可重复使用，并防止针头移除，以符合安全规定。</p>
</div><p>“We are deeply honored that the EasyPoint Blood Collection Tube Holder with Needle has received a Vizient Innovative Technology designation,” said Thomas Shaw, CEO of Retractable Technologies, Inc. “This recognition affirms our ongoing commitment to developing solutions that provide safety, efficiency, and reliability in healthcare settings. From the very beginning, our mission has been to protect both patients and clinicians through engineering excellence and innovation, and the EasyPoint device reflects that mission in action. We are proud to see our team’s dedication acknowledged by one of the industry’s most respected organizations.”</p>
<div class="lb-trans"><p>“我们深感荣幸，EasyPoint 血液采集管支架及针头获得了 Vizient 的创新技术认证，” Retractable Technologies, Inc.首席执行官 Thomas Shaw 表示。“这一认可确认了我们在医疗环境中开发提供安全、高效和可靠解决方案的持续承诺。从一开始，我们的使命就是通过工程卓越和创新来保护患者和临床医生，而 EasyPoint 设备正是这一使命的体现。我们为团队的奉献精神得到行业内最受尊敬的组织之一的认可而感到自豪。”</p>
</div><p>“Congratulations to Retractable Technologies, Inc. for achieving this peer-designated status,” said Kelly Flaharty, associate vice president, contract operations, Vizient. “Our client council deemed the EasyPoint Blood Collection Tube Holder with Needle worthy of this designation for its potential to make a real difference in the healthcare industry.”</p>
<div class="lb-trans"><p>“祝贺 Retractable Technologies, Inc.获得这一同行认证的地位，” Vizient 合同运营副总裁 Kelly Flaharty 表示。“我们的客户委员会认为 EasyPoint 血液采集管支架及针头值得获得这一认证，因为它在医疗行业中具有真正的影响潜力。”</p>
</div><p><strong>RETRACTABLE</strong></p>
<div class="lb-trans"><p><strong>可回缩</strong></p>
</div><p>Retractable manufactures and markets VanishPoint®, EasyPoint®, and Patient Safe® safety medical products. VanishPoint® syringes, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. EasyPoint® retractable needles can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.</p>
<div class="lb-trans"><p>Retractable 生产和销售 VanishPoint®、EasyPoint®和 Patient Safe®安全医疗产品。VanishPoint®注射器、血液采集和静脉导管产品旨在通过直接从患者体内回缩针头来防止针刺伤害和产品重复使用，有效减少接触被污染针头的风险。Patient Safe®注射器独特设计旨在降低因导管接头污染而导致的血流感染风险。EasyPoint®可回缩针头可与 luer 锁注射器、luer 滑动注射器和预填充注射器一起使用进行注射。EasyPoint®针头还可用于抽取液体和血液采集。Retractable 的产品通过各种专业和一般分销商进行分销。</p>
</div><p>For more information on Retractable, visit its website at www.retractable.com.</p>
<div class="lb-trans"><p>有关 Retractable 的更多信息，请访问其网站 www.retractable.com。</p>
</div><p>Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from such statements.</p>
<div class="lb-trans"><p>本新闻稿中的前瞻性声明是根据 1995 年《私人证券诉讼改革法》的安全港条款作出的，反映了 Retractable 对未来事件的当前看法。Retractable 相信这些前瞻性声明所反映的期望是准确的。然而，Retractable 无法保证这些期望会实现。实际未来表现可能与这些声明存在重大差异。</p>
</div><p>Factors that could cause or contribute to such differences include, but are not limited to: material changes in demand; tariffs; Retractable's ability to maintain liquidity; Retractable's maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.</p>
<div class="lb-trans"><p>可能导致或促成这些差异的因素包括但不限于：需求的重大变化；关税；Retractable 维持流动性的能力；Retractable 维持专利保护的能力；Retractable 维持有利的第三方制造和供应商安排及关系的能力；外贸风险；Retractable 进入市场的能力；生产成本；大型市场参与者在安全市场提供设备的影响；以及其他不时在 Retractable 定期报告中详细说明的风险和不确定性，这些报告已提交给美国证券交易委员会。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTExMTQ2NDE4NzNyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20251114641873r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20251114641873/en/</p>
<div class="lb-trans"><p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251114641873/en/</p>
</div><p>Retractable Technologies, Inc.</p>
<div class="lb-trans"><p>Retractable Technologies, Inc.</p>
</div><p>John W. Fort III, 888-806-2626 or 972-294-1010</p>
<div class="lb-trans"><p>John W. Fort III, 888-806-2626 或 972-294-1010</p>
</div><p>Vice President, Chief Financial Officer, and Chief Accounting Officer</p>
<div class="lb-trans"><p>副总裁、首席财务官和首席会计官</p>
</div><p>Source: Retractable Technologies, Inc.</p>
<div class="lb-trans"><p>来源：Retractable Technologies, Inc.</p>
</div>

Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle | RVP Stock News

Retractable Technologies, Inc. 因其 EasyPoint 血液采集管持针器获得了来自 Vizient 的创新技术认证 | RVP 股票新闻